These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39109448)

  • 1. Inhalable mucin-permeable nanomicelles deliver antibiotics for effective treatment of chronic pneumonia.
    Jiang Z; Huo S; Qiao L; Lin P; Fu L; Wu Y; Li W; Bian C; Li Y; Li N; Cheng H; Nie X; Ding S
    J Mater Chem B; 2024 Aug; 12(34):8465-8476. PubMed ID: 39109448
    [No Abstract]   [Full Text] [Related]  

  • 2. On-demand pH-sensitive surface charge-switchable polymeric micelles for targeting Pseudomonas aeruginosa biofilms development.
    Chen X; Guo R; Wang C; Li K; Jiang X; He H; Hong W
    J Nanobiotechnology; 2021 Apr; 19(1):99. PubMed ID: 33836750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial biofilm destruction by size/surface charge-adaptive micelles.
    Chen M; Wei J; Xie S; Tao X; Zhang Z; Ran P; Li X
    Nanoscale; 2019 Jan; 11(3):1410-1422. PubMed ID: 30608101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
    Lababidi N; Ofosu Kissi E; Elgaher WAM; Sigal V; Haupenthal J; Schwarz BC; Hirsch AKH; Rades T; Schneider M
    J Control Release; 2019 Nov; 314():62-71. PubMed ID: 31654686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
    Lababidi N; Montefusco-Pereira CV; de Souza Carvalho-Wodarz C; Lehr CM; Schneider M
    Eur J Pharm Biopharm; 2020 Dec; 157():200-210. PubMed ID: 33222771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasmall TPGS-PLGA Hybrid Nanoparticles for Site-Specific Delivery of Antibiotics into
    Wan F; Bohr SS; Kłodzińska SN; Jumaa H; Huang Z; Nylander T; Thygesen MB; Sørensen KK; Jensen KJ; Sternberg C; Hatzakis N; Mørck Nielsen H
    ACS Appl Mater Interfaces; 2020 Jan; 12(1):380-389. PubMed ID: 31804792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y; Huang J; Li L; Liu L
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Azithromycin and Gentamicin for Efficient Treatment of Pseudomonas aeruginosa Infections.
    Ren H; Liu Y; Zhou J; Long Y; Liu C; Xia B; Shi J; Fan Z; Liang Y; Chen S; Xu J; Wang P; Zhang Y; Zhu G; Liu H; Jin Y; Bai F; Cheng Z; Jin S; Wu W
    J Infect Dis; 2019 Oct; 220(10):1667-1678. PubMed ID: 31419286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
    Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G
    Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
    Wang X; Cai Y; Xing H; Wu W; Wang G; Li L; Chen J
    BMC Microbiol; 2016 Jun; 16(1):124. PubMed ID: 27341798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast Biofilm Penetration and Anti-PAO1 Activity of Nebulized Azithromycin in Nanoarchaeosomes.
    Altube MJ; Martínez MMB; Malheiros B; Maffía PC; Barbosa LRS; Morilla MJ; Romero EL
    Mol Pharm; 2020 Jan; 17(1):70-83. PubMed ID: 31617725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Combined Ciprofloxacin and azithromycin free and nano formulations to control biofilm producing Pseudomonas aeruginosa isolated from burn wounds.
    Raouf M; Essa S; El Achy S; Essawy M; Rafik S; Baddour M
    Indian J Med Microbiol; 2021 Jan; 39(1):81-87. PubMed ID: 33460732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia.
    Wang Q; Mi G; Hickey D; Li Y; Tu J; Webster TJ; Shen Y
    Biomaterials; 2018 Apr; 160():107-123. PubMed ID: 29407340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
    Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M
    J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of polymyxin B-doxycycline in combination against Pseudomonas aeruginosa in vitro and in a mouse model of acute pneumonia.
    Gaurav A; Kothari A; Omar BJ; Pathania R
    Int J Antimicrob Agents; 2020 Jul; 56(1):106022. PubMed ID: 32439481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucus polymer concentration and
    Greenwald MA; Meinig SL; Plott LM; Roca C; Higgs MG; Vitko NP; Markovetz MR; Rouillard KR; Carpenter J; Kesimer M; Hill DB; Schisler JC; Wolfgang MC
    mBio; 2024 Jun; 15(6):e0345123. PubMed ID: 38651896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
    Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
    [No Abstract]   [Full Text] [Related]  

  • 19. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
    Hoffmann N; Lee B; Hentzer M; Rasmussen TB; Song Z; Johansen HK; Givskov M; Høiby N
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3677-87. PubMed ID: 17620382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.